Evidence map›Paper›PMID 28152570›Full record

ArticleInternational journal of cancer2017

Niacin intake and risk of skin cancer in US women and men.

Sang Min Park, Tricia Li, Shaowei Wu, Wen-Qing Li, Martin Weinstock, Abrar A Qureshi, Eunyoung Cho

Open access · bronzeAbstract read
In one paragraph

Article in International journal of cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. [Alternative treatment options for periorbital basal cell carcinoma].Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Sang Min ParkChanning Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Tricia LiChanning Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Shaowei WuDepartment of Dermatology, The Warren Alpert Medical School, Brown University, Providence, RI.
Wen-Qing LiDepartment of Dermatology, The Warren Alpert Medical School, Brown University, Providence, RI.
Martin WeinstockDepartment of Dermatology, The Warren Alpert Medical School, Brown University, Providence, RI.
Abrar A QureshiChanning Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Eunyoung ChoChanning Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
Brigham and Women's Hospital · USBrown University · USHarvard University · USPeking University · CNRhode Island Hospital · US

Funding

Life Course Cancer Epidemiology Cohort in WomenU01CA176726 · NCI · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI ELIASSEN, A. HEATHER, WILLETT, WALTER C. · 2018 to 2025
$22.4M
Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3M
Life Course Cancer Epidemiology Cohort in WomenUM1CA176726 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WILLETT, WALTER C. · 2013 to 2017
$15.7M
Cancer Epidemiology Cohort in Male Health ProfessionalsUM1CA167552 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI WILLETT, WALTER C. · 2012 to 2016
$11.5M
Molecular signatures of melanoma histology and progression: A Population Based AR01CA137365 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI QURESHI, ABRAR A · 2009 to 2013
$1.4M
Psoralens and melanomaR21CA198216 · NCI · BROWN UNIVERSITY · PI CHO, EUNYOUNG · 2015 to 2016
$432k
NCI NIH HHS R01 CA137365NCI NIH HHS R21 CA198216NCI NIH HHS U01 CA176726NCI NIH HHS UM1 CA167552NCI NIH HHS UM1 CA176726NCI NIH HHS UM1 CA186107
6 · The paper itself

Abstract

A recent clinical trial found a protective role of niacinamide, a derivative of niacin, against skin cancer recurrence. However, there is no epidemiologic study to assess the association between niacin intake and risk of skin cancer [basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and melanoma]. We prospectively evaluated whether total, dietary and supplemental niacin intake was associated with skin cancer risk based on 72,308 women in the Nurses' Health Study (1984-2010) and 41,808 men in the Health Professionals Follow-up Study (1986-2010). Niacin intake was assessed every 2 to 4 years during follow-up and cumulative averaged intake. Cox proportional hazard models were used to compute the hazard ratios (HR) and 95% confidence intervals (CI) and cohort-specific results were pooled using a random-effects model. During the follow-up, we documented 23,256 BCC, 2,530 SCC and 887 melanoma cases. Total niacin intake was inversely associated with SCC risk; the pooled HR for top vs. bottom quintiles was 0.84 (95% CI = 0.74-0.95; p

Indexed as

Basal Cell CarcinomaCarcinoma, Squamous CellDietFemaleHumansMaleMelanomaNeoplasm Recurrence, LocalNiacinProportional Hazards ModelsRisk FactorsSkin NeoplasmsUnited StatesNiacinbasal cell carcinomamelanomaniacin intakeskin cancersquamous cell carcinoma

Identifiers

PMID28152570
PMCPMC5937269
OpenAlexW2585564425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.